BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 10084762)

  • 1. De novo malignances in pediatric organ transplant recipients.
    Penn I
    Pediatr Transplant; 1998 Feb; 2(1):56-63. PubMed ID: 10084762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoplastic complications of transplantation.
    Penn I
    Semin Respir Infect; 1993 Sep; 8(3):233-9. PubMed ID: 8016484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
    Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
    Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
    Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
    Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors.
    Kelly DM; Emre S; Guy SR; Miller CM; Schwartz ME; Sheiner PA
    Cancer; 1998 Sep; 83(6):1237-43. PubMed ID: 9740091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and incidence of cancer following cyclosporine therapy.
    Penn I; First MR
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):210-5. PubMed ID: 3515690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and treatment of neoplasia after transplantation.
    Penn I
    J Heart Lung Transplant; 1993; 12(6 Pt 2):S328-36. PubMed ID: 8312352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Melanoma in organ transplant patients].
    Lévêque L; Dalac S; Dompmartin A; Louvet S; Euvrard S; Catteau B; Hazan M; Schollhamer M; Aubin F; Dreno B; Daguin P; Chevrant-Breton J; Frances C; Bismuth MJ; Tanter Y; Lambert D
    Ann Dermatol Venereol; 2000 Feb; 127(2):160-5. PubMed ID: 10739973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the incidence of de novo solid malignancies after heart transplantation to that in the general population.
    Kellerman L; Neugut A; Burke B; Mancini D
    Am J Cardiol; 2009 Feb; 103(4):562-6. PubMed ID: 19195521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of lymphoproliferative disease after liver transplantation.
    Marqués E; Jiménez C; Manrique A; Vallejo GH; Clemares M; Ortega P; Moreno E
    Transplant Proc; 2008 Nov; 40(9):2988-9. PubMed ID: 19010169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumors after renal and cardiac transplantation.
    Penn I
    Hematol Oncol Clin North Am; 1993 Apr; 7(2):431-45. PubMed ID: 8468275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo malignancy in pediatric organ transplant recipients.
    Penn I
    J Pediatr Surg; 1994 Feb; 29(2):221-6; discussion 227-8. PubMed ID: 8176596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin cancers following pediatric organ transplantation.
    Euvrard S; Kanitakis J; Cochat P; Claudy A
    Dermatol Surg; 2004 Apr; 30(4 Pt 2):616-21. PubMed ID: 15061845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer incidence in 854 kidney transplant recipients from a single institution: comparison with normal population and with patients under dialytic treatment.
    Montagnino G; Lorca E; Tarantino A; Bencini P; Aroldi A; Cesana B; Braga M; Lonati F; Ponticelli C
    Clin Transplant; 1996 Oct; 10(5):461-9. PubMed ID: 8930463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo cancers and post-transplant lymphoproliferative disorder in adult liver transplantation.
    Aseni P; Vertemati M; De Carlis L; Sansalone CV; Bonacina E; Minola E; Oreste P; Vizzotto L; Rondinara G
    Pathol Int; 2006 Nov; 56(11):712-5. PubMed ID: 17040297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo tumors after liver transplantation: a single-institution experience.
    Sanchez EQ; Marubashi S; Jung G; Levy MF; Goldstein RM; Molmenti EP; Fasola CG; Gonwa TA; Jennings LW; Brooks BK; Klintmalm GB
    Liver Transpl; 2002 Mar; 8(3):285-91. PubMed ID: 11910575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M; Desai DM; Cox KL; Berquist WE; Esquivel CO; Millan MT
    Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.
    Ju MK; Joo DJ; Kim SJ; Huh KH; Kim MS; Jeon KO; Kim HJ; Kim SI; Kim YS
    Transpl Int; 2009 Jun; 22(6):644-53. PubMed ID: 19220824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Skin cancer in renal transplant recipients].
    Mangino M; Schena FP
    G Ital Nefrol; 2010; 27 Suppl 50():S75-80. PubMed ID: 20922700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depressed immunity and the development of cancer.
    Penn I
    Cancer Detect Prev; 1994; 18(4):241-52. PubMed ID: 7982234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.